(Q59416900)
Statements
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa (English)
J M Rabey
I Sagi
M Huberman
E Melamed
N Giladi
R Inzelberg
R Djaldetti
C Klein
G Berecz
Rasagiline Study Group
1 November 2000